Pathology News | Tissuepathology.com

Techcyte announces $15 Million Capital Raise Led by Van Tuyl Companies to Support Growth and Path to Profitability

Erica Goodpaster — Fri, 01 May 2026 12:32:48 +0000

Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced the completion of a $15 million capital raise led by Van Tuyl Companies, with participation from existing investors Zoetis Inc. (“Zoetis”) and Mayo Clinic. This funding reinforces Techcyte’s ability to execute on its strategic priorities and supports its path to […]

The post Techcyte announces $15 Million Capital Raise Led by Van Tuyl Companies to Support Growth and Path to Profitability first appeared on Tissuepathology.com.

What’s New in Glencoe Software’s PathViewer 3.16.1

Erica Goodpaster — Thu, 30 Apr 2026 13:30:19 +0000

From the Glencoe Software blog We are excited to announce the release of PathViewer 3.16.1! This version introduces enhanced mask support, improved channel controls, and expanded dataset-level annotation customization. Auto-Min/Max Channel Control An auto-min/max button has been added to the Viewing Options channel controls, allowing all visible channels to be scaled to their histogram range […]

The post What’s New in Glencoe Software’s PathViewer 3.16.1 first appeared on Tissuepathology.com.

Fimlab expands utilization of Aiforia’s clinical AI solutions

Erica Goodpaster — Mon, 27 Apr 2026 12:10:53 +0000

Fimlab Laboratories expands the use of Aiforia’s AI solutions for breast cancer diagnostics, bringing multi-organ Ki67 biomarker quantification into routine clinical use. Aiforia Technologies Plc, Press Release, April 27, 2026 at 9:00 a.m. EEST Aiforia Technologies Plc announced today that Fimlab Laboratories in Finland has expanded the use of Aiforia’s AI solutions in routine clinical […]

The post Fimlab expands utilization of Aiforia’s clinical AI solutions first appeared on Tissuepathology.com.

Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026

Erica Goodpaster — Fri, 24 Apr 2026 12:37:33 +0000

CAMBRIDGE, UK — April 21, 2026 — Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual Meeting 2026, further proving its unique capability to unlock complete biological blueprints essential for drug discovery and clinical decision-making. The Company revealed […]

The post Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026 first appeared on Tissuepathology.com.

Join Proscia for a Webinar!

Erica Goodpaster — Wed, 22 Apr 2026 12:19:19 +0000

Proscia announces webinar Inside Concentriq: The Product Behind the Top KLAS Score April 28, 2026 | 11am ET | 45 minutes REGISTER NOW Digital Pathology Built for Real-World Practice As digital pathology moves into daily practice, the standard for what a platform should deliver is rising: an experience that works the way pathologists think, operations […]

The post Join Proscia for a Webinar! first appeared on Tissuepathology.com.

American Center for Cancer Research: DNA methylation “fingerprints” identify primary sites in metastatic cancers

Erica Goodpaster — Tue, 21 Apr 2026 13:47:18 +0000

A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22. CUP are metastatic malignancies in which the primary cancer site could not […]

The post American Center for Cancer Research: DNA methylation “fingerprints” identify primary sites in metastatic cancers first appeared on Tissuepathology.com.